# Arcutis Biotherapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2022

- Company: [Arcutis Biotherapeutics, Inc.](/companies/arqt.md) (CIK 1787306)
- Form: 10-K/A
- Filed: 2023-09-15
- Accepted by EDGAR: Sep 15, 2023, 16:07 ET
- Period: 2022-12-31
- Accession: 0001787306-23-000103
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1787306/000178730623000103/arqt-20221231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1787306/000178730623000103/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1787306/000178730623000103/arqt-20221231.htm

Filed Sep 15, 2023.
Source: SEC EDGAR, the filing index for accession 0001787306-23-000103. Last ingested by Listed: Nov 4, 2026, 20:19 ET. No prices; not investment advice.